| Matthew Brooks, MD | |
|
640 S State St, Dover, DE 19901-3530 | |
| (302) 744-6156 | |
| Not Available |
| Full Name | Matthew Brooks |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Location | 640 S State St, Dover, Delaware |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1750573598 | NPI | - | NPPES |
| Entity Name | Emergency Care Services Of Pennsylvania Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1114955010 PECOS PAC ID: 1759301799 Enrollment ID: O20051206000046 |
News Archive
Bristol-Myers Squibb Company today announced that the U.S. Food and Drug Administration (FDA) has accepted for review a supplemental Biologics License Application (sBLA) for the subcutaneous formulation of ORENCIA® (abatacept), a treatment for adult patients with moderate to severe rheumatoid arthritis (RA) administered through an injection into the skin. Bristol-Myers Squibb submitted the sBLA to the FDA for the subcutaneous formulation of ORENCIA and received confirmation of its receipt on October 4, 2010.
A thyroid-hormone-like substance that works specifically on the liver reduces blood cholesterol with no serious side effects. This according to a clinical trial conducted by researchers from the Swedish medical university Karolinska Institutet, amongst other centres, published today in the top-ranking scientific periodical The New England Journal of Medicine.
A new analysis published by THE SAGE GROUP concludes that atherosclerotic peripheral arterial disease (PAD) afflicts over 20 million in India. Both PAD and CLI represent major and significantly underestimated problems for the Indian economy and healthcare system.
BSD Medical Corporation (www.bsdmedical.com) today provided an update on the U.S. Food and Drug Administration's (FDA) review of the Company's Humanitarian Device Exemption (HDE) marketing submission for the Company's BSD-2000 Hyperthermia System.
› Verified 7 days ago
| Entity Name | Prospect Health Access Network Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1568819084 PECOS PAC ID: 5698065142 Enrollment ID: O20160613000737 |
News Archive
Bristol-Myers Squibb Company today announced that the U.S. Food and Drug Administration (FDA) has accepted for review a supplemental Biologics License Application (sBLA) for the subcutaneous formulation of ORENCIA® (abatacept), a treatment for adult patients with moderate to severe rheumatoid arthritis (RA) administered through an injection into the skin. Bristol-Myers Squibb submitted the sBLA to the FDA for the subcutaneous formulation of ORENCIA and received confirmation of its receipt on October 4, 2010.
A thyroid-hormone-like substance that works specifically on the liver reduces blood cholesterol with no serious side effects. This according to a clinical trial conducted by researchers from the Swedish medical university Karolinska Institutet, amongst other centres, published today in the top-ranking scientific periodical The New England Journal of Medicine.
A new analysis published by THE SAGE GROUP concludes that atherosclerotic peripheral arterial disease (PAD) afflicts over 20 million in India. Both PAD and CLI represent major and significantly underestimated problems for the Indian economy and healthcare system.
BSD Medical Corporation (www.bsdmedical.com) today provided an update on the U.S. Food and Drug Administration's (FDA) review of the Company's Humanitarian Device Exemption (HDE) marketing submission for the Company's BSD-2000 Hyperthermia System.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Matthew Brooks, MD 640 S. State Street, Mail Code 3055, Dover, DE 19901-3530 Ph: (302) 480-1688 | Matthew Brooks, MD 640 S State St, Dover, DE 19901-3530 Ph: (302) 744-6156 |
News Archive
Bristol-Myers Squibb Company today announced that the U.S. Food and Drug Administration (FDA) has accepted for review a supplemental Biologics License Application (sBLA) for the subcutaneous formulation of ORENCIA® (abatacept), a treatment for adult patients with moderate to severe rheumatoid arthritis (RA) administered through an injection into the skin. Bristol-Myers Squibb submitted the sBLA to the FDA for the subcutaneous formulation of ORENCIA and received confirmation of its receipt on October 4, 2010.
A thyroid-hormone-like substance that works specifically on the liver reduces blood cholesterol with no serious side effects. This according to a clinical trial conducted by researchers from the Swedish medical university Karolinska Institutet, amongst other centres, published today in the top-ranking scientific periodical The New England Journal of Medicine.
A new analysis published by THE SAGE GROUP concludes that atherosclerotic peripheral arterial disease (PAD) afflicts over 20 million in India. Both PAD and CLI represent major and significantly underestimated problems for the Indian economy and healthcare system.
BSD Medical Corporation (www.bsdmedical.com) today provided an update on the U.S. Food and Drug Administration's (FDA) review of the Company's Humanitarian Device Exemption (HDE) marketing submission for the Company's BSD-2000 Hyperthermia System.
› Verified 7 days ago
Aaron Fedor, Emergency Medicine Medicare: Medicare Enrolled Practice Location: 640 S State St, Dover, DE 19901 Phone: 302-744-6156 Fax: 302-738-3845 | |
Dr. John P. Gusdon, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 640 S State St, Dover, DE 19901 Phone: 302-744-6156 Fax: 302-735-3845 | |
Dean E. Johnson, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 640 S State St, Dover, DE 19901 Phone: 302-744-6156 Fax: 302-735-3845 | |
Frank Mayer Iii, Emergency Medicine Medicare: Medicare Enrolled Practice Location: 640 S State St, Dover, DE 19901 Phone: 302-674-4700 Fax: 302-735-3845 | |
Dr. Charles Allen, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 1275 So State St, Dover, DE 19901 Phone: 302-678-1302 Fax: 302-678-4550 | |
Dr. Julia Michelle Cullen, D.O. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 640 S State St, Dover, DE 19901 Phone: 302-744-6156 Fax: 302-735-3845 | |
Dr. Lareb Altaf, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 640 S State St, Dover, DE 19901 Phone: 302-744-6999 |